首页> 美国卫生研究院文献>Bariatric Surgical Practice and Patient Care >Efficacy of Intravenous Acetaminophen in Length of Stay and Postoperative Pain Control in Laparoscopic Roux-en-Y Gastric Bypass Surgery Patients
【2h】

Efficacy of Intravenous Acetaminophen in Length of Stay and Postoperative Pain Control in Laparoscopic Roux-en-Y Gastric Bypass Surgery Patients

机译:腹腔镜Roux-en-Y胃绕道手术患者静脉注射对乙酰氨基酚的住院时间和术后疼痛控制的疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Opiate-based pain medications may incur adverse effects following bariatric surgery. The aim of this study was to evaluate the efficacy of intravenous Acetaminophen (IVAPAP) on length of stay (LOS) after laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery.>Methods: This was a prospective, double-blind, randomized controlled trial conducted from October 2011 to March 2014 at a 416-bed teaching hospital. Eighty-nine total patients were included (control group, n = 45; treatment group, n = 44). Patients were administered either 1000 mg of IVAPAP or placebo every 6 h beginning preoperatively and continuing for four doses. LOS, total narcotic consumption, pain and nausea scores, time to return of flatus (ROF), and postoperative rescue pain medication used were measured during the first 24 h after surgery.>Results: LOS was significantly decreased in the treatment group compared with control (2.72 days vs. 3.18 days; p = 0.03). There was significant reduction in time to ROF (1.87 days vs. 2.24 days; p = 0.04). Pain was significantly decreased in the first 2 postoperative hours in the treatment group (p = 0.02). Total opioid consumption, postoperative nausea scores, and use of rescue pain medications were not affected.>Conclusions: The use of IVAPAP significantly decreases LOS following LRYGB, improves acute postoperative pain control, and mediates quicker return of bowel function.
机译:>背景:基于阿片类的止痛药可能会在减肥手术后产生不良影响。这项研究的目的是评估腹腔镜Roux-en-Y胃搭桥术(LRYGB)术后静脉对乙酰氨基酚(IVAPAP)对住院时间(LOS)的疗效。>方法:这项双盲,随机对照试验于2011年10月至2014年3月在拥有416张床的教学医院进行。总共包括89名患者(对照组,n = 45;治疗组,n = 44)。术前每6h给患者服用1000μmgIVAPAP或安慰剂,并持续4剂。在手术后的最初24小时内测量了LOS,麻醉剂总消耗量,疼痛和恶心评分,肠扁平气恢复时间(ROF)以及术后使用的止痛药。>结果:治疗组与对照组比较(2.72天vs.3.18天; p = 0.03)。到达ROF的时间显着减少(1.87天比2.24天; p = 0.04)。在治疗组的最初两个小时内疼痛明显降低(p = 0.02)。阿片类药物的总摄入量,术后恶心评分和急救止痛药的使用均未受影响。>结论:使用IVAPAP可以显着降低LRYGB术后的LOS,改善急性术后疼痛控制,并介导肠功能更快恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号